Associate Professor of Medicine, Beth Israel Deaconess Medical Center
Gastroenterology
Dr. Anthony Lembo, MD
|
|
Give Review
Anthony Lembo works in the field of Gastroenterology. He attended Tufts University School of Medicine. Tufts University School of Medicine is ranked 49/52 in Research/PrimaryCare. He has 1 awards "Meaningful Use Stage 1 Certification". Doctor Anthony Lembo, MD has written publications. He has 74 publications published with PubMed. The lastest paper is: 'Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation.' He accepts Medicare.
Publications
- Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation.
- Current and emerging drug options in the treatment of diarrhea predominant irritable bowel Syndrome.
- New and Emerging Treatment Options for Irritable Bowel Syndrome.
- Inpatient burden of childhood functional GI disorders in the USA: an analysis of national trends in the USA from 1997 to 2009.
- Emergency Department Burden of Constipation in the United States from 2006 to 2011.
- Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C.
- Complementary and Alternative Medicine Use Is Prevalent Among Patients with Gastrointestinal Diseases.
- Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients.
- The impact of Abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two...
- Opioid-Induced Bowel Dysfunction: Epidemiology, Pathophysiology, Diagnosis, and Initial Therapeutic Approach.
- Introduction: opioid-induced constipation.
- American Gastroenterological Association Technical Review on the Pharmacological Management of Irritable Bowel Syndrome.
- Complementary and Alternative Medicine Use by US Adults With GastroIntestinal Conditions: Results from the 2012 National Health Interview Survey.
- Editorial: IBS With Constipation, Functional Constipation, Painful and Non-Painful Constipation: e Pluribusâ¦Plures?
- Safety and tolerability of rifaximin for the treatment of irritable bowel Syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-control...
- Inpatient burden of constipation in the United States: an analysis of national trends in the United States from 1997 to 2010.
- Irritable Bowel Syndrome subtypes: constipation, diarrheaâ¦and mixed bowel pattern: Tertium datur.
- In-patient discharge rates for the irritable bowel Syndrome - an analysis of national trends in the United States from 1997 to 2010.
- Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-C.
- Opioid-induced bowel dysfunction.
- Diagnosing IBS: No more million dollar workup?
- The Crohn's Disease activity index (CDAI) is similarly elevated in patients with Crohn's Disease and in patients with irritable bowel syndrome.
- An evaluation of the FDA Responder Endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials.
- Diagnostic testing for dyssynergic defecation in chronic constipation: meta-analysis.
- Motility disorders of the colon and rectum.
- A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel Syndrome with ...
- Neurotrophin-3 improves functional constipation.
- Irritable bowel Syndrome: evaluation and treatment.
- Alosetron in irritable bowel syndrome: strategies for its use in a common gastroIntestinal disorder.
- Chronic constipation.
- A novel endoscopic full-thickness plicator for the treatment of GERD: A pilot study.
- Questions & answers. I frequently get constipated. How can I prevent this uncomfortable condition?
- Endoscopic full-thickness plication for the treatment of GERD: a multicenter trial.
- When is it appropriate to use over-the-counter antidiarrheal medication, and when does diarrhea call for a doctor's visit?
- Visceral hypersensitivity in noncardiac chest Pain.
- Tegaserod does not alter fasting or meal-induced biliary tract motility.
- Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel Syndrome: analysis of two controlled trials.
- Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial.
- Irritable bowel Syndrome medications side effects survey.
- Review of tegaserod in the treatment of irritable bowel Syndrome.
- Endoscopic full-thickness plication for the treatment of GERD: 12-month follow-up for the North American open-label trial.
- Irritable bowel Syndrome: toward an understanding of severity.
- Investigating placebo effects in irritable bowel Syndrome: a novel research design.
- A 54-year-old woman with constipation-predominant irritable bowel Syndrome.
- Peripheral opioids for functional GI Disease: a reappraisal.
- Current gut-directed therapies for irritable bowel Syndrome.
- Endoscopic full-thickness plication for the treatment of gastroesophageal reflux Disease: A randomized, sham-controlled trial.
- Effects of probiotic bacteria on gastroIntestinal motility in guinea-pig isolated tissue.
- Effectiveness of recruitment in clinical trials: an analysis of methods used in a trial for irritable bowel Syndrome patients.
- Endoscopic full-thickness plication for the treatment of GERD: Five-year long-term multicenter results.
- Update: a 54-year-old woman with constipation-predominant irritable bowel Syndrome.
- Spasm, nutcracker, and IEM: real or manometry findings?
- Components of placebo effect: randomised controlled trial in patients with irritable bowel Syndrome.
- Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile tox...
- Pilot study on the effect of linaclotide in patients with chronic constipation.
- Psychiatric disorder, irritable bowel syndrome, and extra-Intestinal symptoms in a population-based sample of twins.
- Adequate relief in a treatment trial with IBS patients: a prospective assessment.
- Delayed radionucleotide Gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis.
- A treatment trial of acupuncture in IBS patients.
- Developing valid and reliable health utilities in irritable bowel Syndrome: results from the IBS PROOF Cohort.
- Treatment of Helicobacter pylori infection with intra-Gastric violet light phototherapy: a pilot clinical trial.
- "Maybe I made up the whole thing": placebos and patients'' experiences in a randomized controlled trial.
- Patient and practitioner influences on the placebo effect in irritable bowel Syndrome.
- Which patients improve: characteristics increasing sensitivity to a supportive patient-practitioner relationship.
- Efficacy of linaclotide for patients with chronic constipation.
- Linaclotide improves Abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.
- Placebos without deception: a randomized controlled trial in irritable bowel Syndrome.
- Rifaximin therapy for patients with irritable bowel Syndrome without constipation.
- Complementary and alternative medicine for the irritable bowel Syndrome.
- Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation.
- Two randomized trials of linaclotide for chronic constipation.
- Highlights from the 2007 ACG.
- Rifaximin for the treatment of irritable bowel Syndrome.
Schools
Tufts University School Of Medicine
UCLA Med Center
Procedures Preformed
- Anoscopy
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Manometry
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Humana
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- Network Health
- Simplifi
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Meaningful Use Stage 1 Certification
Education
-
Olive View - UCLA Medical Center -
UCLA Medical Center -
Tufts University School of Medicine
Hospital
-
Beth Israel Deaconess Medical Center -
MetroWest Medical Center -
Mount Auburn Hospital -
Newton-Wellesley Hospital
Drug Facts
| NPI NUMBER | 1407826266 | |
| NPPES Provider LastName | LEMBO | |
| NPPES Provider FirstName | ANTHONY | |
| NPPES Provider ZIPCode | 022155400 | |
| NPPES Provider State | MA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 144.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1407826266 |
| Last Name Of The Provider | LEMBO |
| First Name Of The Provider | ANTHONY |
| View All |
Similar Doctors
|
|
Dr. Debra F. Weinstein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory M. Cote, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard Y. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chinweike Ukomadu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheela S. Reddy, MD |
|
|
Dr. David O. Rahni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Cohen, MD |
|
|
Dr. Michael D. Apstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heba Iskandar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ciaran P. Kelly, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Zalman M. Falchuk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nezam H. Afdhal, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|